p/>The Executive Director, Growth & Commercial Excellence in Specialty Diagnostics owns the unified commercial execution framework (messaging, prioritization, and sequencing) across Commercial, Medical Affairs, Marketing, Market Access, Sales Ops, and Lab Ops for a critical enterprise growth priority in Specialty Diagnostics (e.g., Oncology, Neurology, Autoimmune).. It drives product- and indication-specific growth (e.g., OmniSeq Insight, Labcorp Plasma Complete, Plasma Detect, Labcorp Heme NGS) and accelerates adoption by enabling guideline-aligned testing strategies, health system and pathway integration, payer/reimbursement readiness, and data-driven territory optimization.